We develop methodology to bridge scenario analysis and risk forecasting, leveraging their respective strengths in policy settings. The methodology, rooted in Bayesian analysis, addresses the ...

Aircela’s new device, roughly the size of a commercial refrigerator, combines direct air capture (DAC) with on-site fuel synthesis to create gasoline using just air, water, and renewable energy ...

Arakoda ® (tafenoquine) is now available in an 8-count bottle format, according to 60 Degrees Pharmaceuticals.. Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis ...

Dr. Robert Anthony Holton, known as “Bob” to friends and colleagues, was a groundbreaking chemist and the scientist behind the first total synthesis of the cancer drug Taxol. He died ...

Cipla's North America business, contributing 29% of total revenue, grew marginally by 3% and secured drug approvals from ANDA & NDA for Lanreotide Injection, Nilotinib, and Nano Paclitaxel.

WILMINGTON, Del., June 03, 2025--Multiple Incyte Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted at EHA 2025 ...

It is one of three major Novartis products that are nearing the end of their patent lives, along with cancer drug Tasigna (nilotinib) and Promacta (eltrombopag) for thrombocytopaenia, which ...

Novartis revealed this morning that it has decided to trim back its R&D pipeline by around 10% to 136 projects, as it continues its transition into a pure-play innovative medicines company.

Adding the PARP inhibitor niraparib to abiraterone acetate (Akeega) and prednisone significantly reduced the risk of radiographic progression or death by 37% compared with abiraterone acetate and ...

A general method for the intermolecular coupling of aryl halides and amides using a Xantphos/Pd catalyst is described. This system displays good functional group compatibility, and the desired C−N ...